Daraxonrasib Approved for Metastatic Pancreatic Cancer
Key Points FDA approved daraxonrasib (RASONQUE) on August 26, 2026, for adults with metastatic pancreatic adenocarcinoma after at least one
Read MoreKey Points FDA approved daraxonrasib (RASONQUE) on August 26, 2026, for adults with metastatic pancreatic adenocarcinoma after at least one
Read MoreKey Points A multicenter analysis of 787 brain tumor patients evaluated outcomes after laser interstitial thermal therapy (LITT). For newly
Read MoreKey Takeaways Autophagy modulation is emerging as a promising strategy to overcome cisplatin-resistant gastric cancer. Researchers identified several existing drugs
Read MoreKey Points A large meta-analysis of 28 cohort studies found a small but statistically significant association between allergic diseases and
Read MoreKey Highlights A 3-million-cell atlas reveals how aging reshapes breast tissue Decline in immune surveillance may allow cancer cells to
Read MoreSTF-1623 Transforming ‘Cold’ Tumors into ‘Hot’ Tumors Cancer immunotherapy has changed the way certain cancers are treated, especially melanoma, lung,
Read MoreIn a breakthrough led by Baylor College of Medicine, researchers have used Cell Painting technology to uncover plant-based flavonoids with
Read MoreA groundbreaking multi-cancer early detection test (MCED) could reshape cancer screening practices and dramatically improve patient outcomes by identifying malignancies
Read MoreFor years, red wine has been praised for its potential health benefits, thanks to its antioxidant content like resveratrol. Many
Read MoreRecent findings from the Phase III NRG-RTOG 1112 clinical trial, published in JAMA Oncology, reveal that adding stereotactic body radiotherapy
Read More